Similar articles

• [Association of furosemide and amiloride in patients with essential hypertension. Effect on the excretion of Na, K, Cl and on urine volume].

  Chávez de Los Rios JM, Otero Cagide F, Alfaro Cano L, Gatica Laborde V. Chávez de Los Rios JM, et al. Prensa Med Mex. 1978 Mar-Apr;43(3-4):89-94. Prensa Med Mex. 1978. PMID: 364462 Clinical Trial. Spanish. No abstract available.
• [Immediate and long-term antihypertensive effects of nifedipine in mild and moderate hypertension].

  Saragoça MA, Ribeiro AB, Ramos OL. Saragoça MA, et al. Arq Bras Cardiol. 1985 May;44(5):363-6. Arq Bras Cardiol. 1985. PMID: 3911927 Clinical Trial. Portuguese. No abstract available.
• Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.

  Lindroos M, Lehtonen A. Lindroos M, et al. Int J Clin Pharmacol Ther Toxicol. 1984 Dec;22(12):643-5. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6396239 Clinical Trial.
• [Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution].

  Kremer D. Kremer D. Tidsskr Nor Laegeforen. 1983 May 20;103(14):1165-8. Tidsskr Nor Laegeforen. 1983. PMID: 6349006 Clinical Trial. Norwegian. No abstract available.
• Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.

  Moncloa F, Hwang IK, Muccilli AC. Moncloa F, et al. Clin Ther. 1980;3(3):168-75. Clin Ther. 1980. PMID: 7006811 Clinical Trial.